D-0024-2023 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- November 9, 2022
- Initiation Date
- October 18, 2022
- Termination Date
- September 7, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- N/A
Product Description
Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India; NDC 62756-970-83
Reason for Recall
Presence of Foreign Substance
Distribution Pattern
Nationwide with the United States
Code Information
Lot #: DNC1129A, Exp 06/2023 Lot #: DNC1740A, Exp 09/2023